Gene · 282618
Papers3,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission. | PLoS One | 2024 | 38512921 | PubTator, text mining | PubMed |
| Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology. | Neurol Neuroimmunol Neuroinflamm | 2024 | 38484217 | PubTator, text mining | PubMed |
| Statement of Retraction: The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes. | Bioengineered | 2024 | 38376142 | PubTator, text mining | PubMed |
| Modulation of CD8+T cells, NK cells and Th1cytokines by metabolic milieu in decline of HBV-viremia in pregnant women treated with tenofovir-disoproxil from second trimester of pregnancy. | J Reprod Immunol | 2024 | 38367478 | PubTator, text mining | PubMed |
| Systems genetics of influenza A virus-infected mice identifies TRIM21 as a critical regulator of pulmonary innate immune response. | Virus Res | 2024 | 38331257 | PubTator, text mining | PubMed |
| Long-term intermittent hypoxia in mice induces inflammatory pathways implicated in sleep apnea and steatohepatitis in humans. | iScience | 2024 | 38303705 | PubTator, text mining | PubMed |
| Evaluation of the serum levels of CCL2, CCL3, and IL-29 after first and second administrations of the COVID-19 vaccine (Oxford-AstraZeneca). | Immunobiology | 2024 | 38290406 | PubTator, text mining | PubMed |
| Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1. | Med Oncol | 2024 | 38281234 | PubTator, text mining | PubMed |
| Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1. | PLoS One | 2024 | 38277395 | PubTator, text mining | PubMed |
| Impaired STING Activation Due to a Variant in the E3 Ubiquitin Ligase AMFR in a Patient with Severe VZV Infection and Hemophagocytic Lymphohistiocytosis. | J Clin Immunol | 2024 | 38277122 | PubTator, text mining | PubMed |
| Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas. | Nat Commun | 2024 | 38272925 | PubTator, text mining | PubMed |
| Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer. | J Immunother Cancer | 2024 | 38272564 | PubTator, text mining | PubMed |
| IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study. | Cytokine | 2024 | 38271827 | PubTator, text mining | PubMed |
| The functional role of CST1 and CCL26 in asthma development. | Immun Inflamm Dis | 2024 | 38270326 | PubTator, text mining | PubMed |
| Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study. | Nat Commun | 2024 | 38267411 | PubTator, text mining | PubMed |
| The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers. | Sci Transl Med | 2024 | 38266104 | PubTator, text mining | PubMed |
| Development of robust antiviral assays using relevant apical-out human airway organoids. | bioRxiv | 2024 | 38260306 | PubTator, text mining | PubMed |
| Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier. | Fluids Barriers CNS | 2024 | 38200564 | PubTator, text mining | PubMed |
| Cryptosporidium infection of human small intestinal epithelial cells induces type III interferon and impairs infectivity of Rotavirus. | Gut Microbes | 2024 | 38189373 | PubTator, text mining | PubMed |
| Prokaryotic expression of soluble IFN-λ1 recombinant protein with cold-shock system. | Protein Expr Purif | 2024 | 38065246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/282618/papers?page=8